Skip to main content
Clinical Trials/NCT02960867
NCT02960867
Completed
Not Applicable

European Registry of Dialysis Treatment of Pediatric Acute Kidney Injury (AKI)

Mariella Enoc1 site in 1 country1,892 target enrollmentApril 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Kidney Injury
Sponsor
Mariella Enoc
Enrollment
1892
Locations
1
Primary Endpoint
incidence of AKI requiring dialysis in PICU and non-PICU children
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Acute kidney injury (AKI) is a frequent clinical condition in hospitalized, in particular, in critically ill children. Moreover, AKI is an independent predictor of mortality. An incidence of AKI in pediatric intensive care units (PICU) between 10 and 62% has been reported in recent clinical trials adopting pRIFLE or AKIN criteria, with the highest risk present in cardiac surgery patients. Despite significant developments in the management of AKI, the overall mortality rate of patients with AKI has not improved significantly. Currently, there is no consensus concerning the optimum dialysis modalities to adopt in pediatric AKI. No studies have prospectively compared the efficacy of different types of RRT for pediatric AKI. While PD remains the most commonly used modality in children worldwide, over the last decade CRRT has become the preferred treatment modality for critically ill children with AKI in North America.

The investigators have recently conducted a survey among 34 European Pediatric Nephrology Centers in the ESCAPE Network to obtain current information on dialysis management practices in children. Approximately 900 children with AKI requiring dialysis are managed at these 34 centers per year. This number supports the creation of a prospective European AKI registry.

Detailed Description

The main scope of the Registry is to report the epidemiology and outcome of children with AKI treated with dialysis in over 30 Pediatric Nephrology Centers in Europe. Secondary aims are to verify the association of a specific dialysis modality with the outcome and the association of primary disease, co-morbidities, nephrotoxic agents, fluid overload, anuria, basic hemodynamic parameters (BP, HR), basic nutritional intakes (protein and calorie supply) with the outcome. Data capture will be exclusively web-based via electronic case report forms. Every participating site will be provided with a unique code and password that identify the corresponding site.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
April 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Mariella Enoc
Responsible Party
Sponsor Investigator
Principal Investigator

Mariella Enoc

Principal Investigator

Bambino Gesù Hospital and Research Institute

Eligibility Criteria

Inclusion Criteria

  • Children with AKI at Hospital admission or who developed AKI during hospitalization treated with dialysis (PD, HD, CRRT)
  • Age: 0-18 yrs

Exclusion Criteria

  • Children with known preexisting CKD (i.e.: AKI on CKD)

Outcomes

Primary Outcomes

incidence of AKI requiring dialysis in PICU and non-PICU children

Time Frame: 3 years

urine output and serum creatinine

Secondary Outcomes

  • difference in mortality related to dialysis modality(3 years)
  • difference in the primary outcome related to SpO2(3 years)
  • difference in the primary outcome related to severity score(3 years)
  • difference in the primary outcome related to Mean Airway Pressure(3 years)
  • difference in the primary outcome related to paO2(3 years)
  • Mortality rates(3 years)
  • difference in the primary outcome related to duration of mechanical ventilation(3 years)
  • difference in the primary outcome related to FiO2(3 years)

Study Sites (1)

Loading locations...

Similar Trials